医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

Louise Hogan Joins Korn Ferry as Senior Client Partner

2019年07月12日 PM09:00
このエントリーをはてなブックマークに追加


 

LOS ANGELES

Korn Ferry (NYSE:KFY) today announced Louise Hogan has joined the firm as a senior client partner. She specializes in healthcare and life sciences and is based in Korn Ferry’s Melbourne and Sydney offices.

Hogan brings to the firm over 25 years commercial experience in health and life sciences and has held roles in corporate strategy, marketing, sales, research and development. She joins Korn Ferry from a global consulting and search firm where she was a principal in the healthcare and life sciences practice and was pivotal in building the firm’s business in Australia and New Zealand.

Prior to this, Hogan was VP, Asia Pacific, at INC Research (now Syneos Heath), a global clinical research company. There, she was responsible for leading the business development growth program in key markets including China, India, Singapore, Taiwan, South Korea and Japan.

She began her career in a corporate strategy role with GlaxoSmithKline, global healthcare company, where she led their strategic foresight planning and innovation program. She also led the merger integration program for the Australian business.

“Louise is known as a results-driven strategist with strong client relationships and extensive leadership experience in the Asia Pacific region,” said Mike Distefano, president, APAC, Korn Ferry. “She is passionate about building enduring client relationships, identifying and driving strategic changes and delivering measurable results. We are thrilled to have her on board.”

Hogan holds a bachelor’s degree from University of South Australia and a master’s degree in business administration from University of Adelaide.

About Korn Ferry

Korn Ferry is a global organizational consulting firm. We work with clients to design their organizational structures, roles and responsibilities. We help them hire the right people and advise them on how to reward, develop and motivate their workforce. And, we help professionals navigate and advance their careers.

View source version on businesswire.com: https://www.businesswire.com/news/home/20190712005056/en/

CONTACT

Erica Shannon

(214) 665-3040

erica.shannon@kornferry.com

Related Posts Plugin for WordPress, Blogger...

同じカテゴリーの記事 

  • 印尼生命科学与技术学院在NCRM NICHE 2021上赢得第16届Fujio Cup Quiz大赛;印度Rajalakshmi工程学院获得亚军
  • 辉凌将在ACG 2021上展示基于微生物群的在研活体生物治疗药物RBX2660用于治疗艰难梭菌反复感染和IBD患者的获奖真实临床转归分析
  • ShouTi Secures $100 Million Series B Financing to Accelerate Development of Life-Changing Medicines Fueled by Advanced Computational, Structure-Based Drug Design Platform
  • 硕迪B轮成功融资1亿美元,利用先进的计算和结构药物设计平台加速开发改变患者命运的药物
  • CANbridge Pharmaceuticals CAN103 Investigational New Drug Application Approved in China for Treatment of Gaucher Disease